報價延遲最少15分鐘:2026/03/02 07:45 EST
盤前時段
|
||||
|
4.18 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.62
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.42/-1.40
|
|
企業價值
827.82M
|
| 資產負債 |
|
每股賬面淨值
0.90
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
2.98M
|
|
每股收益
--
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology. |
